Interní Med. 2007; 9(2): 63-66

news in the treatment of tobacco dependence

MUDr. Eva Králíková CSc1, MUDr. Ludmila Pohlová2, MUDr. Lenka Štěpánková1
1 Ústav hygieny a epidemiologie a Centrum léčby závislosti na tabáku III. interní kliniky, 1. LF UK a VFN, Praha
2 Centrum léčby závislosti na tabáku III. interní kliniky 1. LF UK a VFN, Praha

Tobacco dependence is a chronic disease which needs treatment: from the short intervention to intensive and long-time support. Current pharmacotherapy includes except of long time used nicotine and bupropion a new medication, invented especially for the treatment of tobacco dependence: varenicline. Varenicline is a partial agonist of α4β2 subtype of acetylcholin – nicotine receptors, typical for heavy dependent smokers. It does not contain nicotine. A GP should pay attention to each smoker in the frame of his/her time possibilities, to follow-up the patient, to suggest the pharmacotherapy of his/her dependence, and those who need it advice to a specialised center.

Keywords: Key words: tobacco dependence, treatment, GP, nicotine replacement therapy, bupropion, varenicline.

Published: March 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Králíková E, Pohlová L, Štěpánková L. news in the treatment of tobacco dependence. Interní Med. 2007;9(2):63-66.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Čupka J, Nešpor K, Králíková E, Dohnal K, Mucha C, Konštacký S. Léčba závislosti na tabáku v ordinaci praktického lékaře, Doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře, Centrum doporučených postupů pro praktické lékaře, nadační fond Praktik, Praha, 2006: 9s.
    2. Fiore MC, Bailey WC, Cohen SJ et al. Treating tobacco use and dependence, Clinical Practice Guideline, Rockville, MD, US Department of Health and Human Services, Public Health Service, 2000.
    3. Gonzales D, Rennard SI, Nides M et al. Varenicline Phase 3 Study Group. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial, JAMA 2006; 296: 47-55. Go to original source... Go to PubMed...
    4. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR. Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial, JAMA, 2006; Jul 5, 296 (1): 56-63. Go to original source... Go to PubMed...
    5. Králíková E, Býma S, Cífková R, Češka R, Dvořák V, Hamanová J, Horký K, Hradec J, Keller O, Konštacký S, Kos S, Kostřica R, Kunešová M, Kvapil M, Langrová K, Mayer O, Petrů V, Popov P, Raboch J, Rosolová H, Roztočil K, Sucharda P, Vorlíček J, Widimský J. Doporučení pro léčbu závislosti na tabáku, Časopis lékařů českých, 144, 2005; 5: 327-333, http://www.cls.cz/archiv/clc5kralikova.pdf.
    6. Peto R, Lopez AD, Boreham J et al. Mortality from smoking in developed countries 1950 - 2000. Oxford, UK, Oxford University Press, 1994, update 2006, www.deathsfromsmoking.net.
    7. Raw M, McNeill A, West R. Smoking cessation: evidence based recommendations for the healthcare system. BMJ. 1999 Jan 16; 318(7177): 182-185. Go to original source... Go to PubMed...
    8. Sovinová H, Sadílek M, Csémy L. Názory a postoje občanů k problematice kouření, výzkumná zpráva, SZÚ, 2006.
    9. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR. Varenicline Phase 3 Study Group: Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial, JAMA, 2006; Jul 5, 296 (1): 64-71. Go to original source... Go to PubMed...
    10. Varenicline. Guidance for health professional on a new prescription-only stop smoking medication, ASH, London, November 2006, www.ash.org.uk.
    11. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Thorax, 2000; 55: 987-999. Go to original source... Go to PubMed...
    12. World Health Organization: International statistical classification of diseases and related health problems, 10th Revision, Geneva, Switzerland, World Health Organization, 1992.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.